GlycoBAR mission is to help the pharma industry to eliminate hemolytic antibodies from plasma and plasma derivative products. Initially we are targeting specifically blood group anti A and anti B antibodies purification from blood, plasma and plasma fractionation products.
GlycoBAR is located in one of the most important Glyco-science Research Clusters worldwide, called Glyco-Alps, comprising seventeen research labs and hundreds of carbohydrates researchers. We are especially close to CERMAV, a CNRS organization which created the technology that GlycoBAR uses.
 |  |  |
